BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · IEX Real-Time Price · USD

88.63

-1.44 (-1.60%)

At close: Apr 19, 2024, 4:00 PM

90.00

+1.37 (1.55%)

After-hours: Apr 19, 2024, 4:23 PM EDT

BioMarin Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Revenue	2,419	2,096	1,846	1,860	1,704	1,491	1,314	1,117	889.9	749.28	Upgrade
Revenue Growth (YoY)	15.42%	13.53%	-0.76%	9.18%	14.27%	13.52%	17.62%	25.50%	18.77%	36.61%	Upgrade
Cost of Revenue	514.85	483.67	470.52	524.27	359.47	315.26	241.79	209.62	152.01	122.27	Upgrade
Gross Profit	1,904	1,612	1,376	1,336	1,345	1,176	1,072	907.23	737.89	627.02	Upgrade
Selling, General & Admin	937.29	854.01	759.38	737.67	680.92	604.35	554.34	476.59	402.27	302.16	Upgrade
Research & Development	746.77	649.61	628.79	628.12	715.01	696.33	610.75	661.91	634.81	461.54	Upgrade
Other Operating Expenses	62.21	-40.81	69.93	13.84	49.11	-1.21	-78.53	572.17	-188.49	-43.79	Upgrade
Operating Expenses	1,746	1,463	1,458	1,380	1,445	1,299	1,087	1,711	848.59	719.91	Upgrade
Operating Income	158.1	149.56	-82.34	-43.44	-100.46	-123.52	-14.7	-803.43	-110.7	-92.89	Upgrade
Interest Expense / Income	17.34	15.97	15.34	29.31	23.46	43.66	42.71	39.5	38.24	36.64	Upgrade
Other Expense / Income	-47.8	-15.98	-22.33	-23.75	-29.11	-24.48	-21.53	-11.88	5.78	-4.67	Upgrade
Pretax Income	188.56	149.58	-75.35	-49	-94.81	-142.71	-35.88	-831.05	-154.72	-124.87	Upgrade
Income Tax	20.92	8.02	-11.27	-903.03	-70.96	-65.49	81.17	-200.84	17.08	9.1	Upgrade
Net Income	167.65	141.56	-64.08	854.03	-23.85	-77.21	-117.04	-630.21	-171.8	-133.97	Upgrade
Net Income Growth	18.43%	-	-	-	-	-	-	-	-	-	Upgrade
Shares Outstanding (Basic)	188	185	183	181	179	177	174	166	160	146	Upgrade
Shares Outstanding (Diluted)	192	189	183	192	179	177	174	166	160	146	Upgrade
Shares Change	1.39%	3.34%	-4.60%	7.06%	1.00%	1.63%	4.94%	3.87%	9.34%	6.24%	Upgrade
EPS (Basic)	0.89	0.76	-0.35	4.72	-0.13	-0.44	-0.67	-3.80	-1.07	-0.92	Upgrade
EPS (Diluted)	0.87	0.75	-0.35	4.50	-0.13	-0.44	-0.67	-3.81	-1.07	-0.92	Upgrade
EPS Growth	16.00%	-	-	-	-	-	-	-	-	-	Upgrade
Free Cash Flow	62.57	158.27	208.96	38.21	-71.76	-74.41	-207.98	-376.22	-447.15	-187.48	Upgrade
Free Cash Flow Per Share	0.33	0.85	1.14	0.21	-0.40	-0.42	-1.19	-2.27	-2.79	-1.28	Upgrade
Gross Margin	78.72%	76.92%	74.52%	71.82%	78.91%	78.86%	81.59%	81.23%	82.92%	83.68%	Upgrade
Operating Margin	6.54%	7.14%	-4.46%	-2.33%	-5.90%	-8.28%	-1.12%	-71.94%	-12.44%	-12.40%	Upgrade
Profit Margin	6.93%	6.75%	-3.47%	45.90%	-1.40%	-5.18%	-8.91%	-56.43%	-19.31%	-17.88%	Upgrade
Free Cash Flow Margin	2.59%	7.55%	11.32%	2.05%	-4.21%	-4.99%	-15.83%	-33.69%	-50.25%	-25.02%	Upgrade
Effective Tax Rate	11.09%	5.36%	-	-	-	-	-	-	-	-	Upgrade
EBITDA	310.28	267.52	48.03	85.48	33.95	-3.37	94.69	-694.64	-69.29	-42.36	Upgrade
EBITDA Margin	12.83%	12.76%	2.60%	4.59%	1.99%	-0.23%	7.21%	-62.20%	-7.79%	-5.65%	Upgrade
Depreciation & Amortization	104.39	101.97	108.04	105.17	105.3	95.67	87.86	96.91	47.19	45.87	Upgrade
EBIT	205.9	165.55	-60.01	-19.69	-71.35	-99.04	6.83	-791.55	-116.48	-88.23	Upgrade
EBIT Margin	8.51%	7.90%	-3.25%	-1.06%	-4.19%	-6.64%	0.52%	-70.87%	-13.09%	-11.77%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).